Roche and Hansoh Expand ADC Alliance

Company Hansoh Pharma; Roche Event Type Collaboration and Licensing Deal (second ADC alliance) Modality Antibody-drug conjugate (Hansoh proprietary ADC platform) Asset Two undisclosed Hansoh preclinical ADC programs plus multiple Roche-proposed targets Target Undisclosed Disease Area Oncology (tumor types undisclosed) Summary Hansoh Pharma and Roche entered…